-
August 26, 2016 Lupin Receives Tentative Approval for Generic Paxil CR® Tablets
-
August 24, 2016 Lupin Receives FDA Approval for Generic Zyvox® Tablets
-
August 22, 2016 Lupin Receives Approval for Acotiamide Tablets to Treat Functional Dyspepsia
-
August 17, 2016 Lupin Receives FDA Approval for Potassium Chloride Extended-Release Capsules
-
August 10, 2016 Lupin Receives FDA Approval for Generic Klor-Con® Extended-Release Tablets
-
August 9, 2016 Record Sales & Profits – Quarter I FY2017
-
August 2, 2016 Lupin Acquires Branded Product Portfolio from Shionogi in Japan
-
July 27, 2016 Lupin Receives Tentative Approval for Generic Lexiva® Tablets, 700 mg from US FDA
-
July 20, 2016 Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications